Newpath Partners
Overview
Newpath Partners is a venture capital firm dedicated to excellent science and to forming partnerships based on trust and a shared vision . The firm focuses on venture capital investments in disruptive treatments and technologies in the life sciences space . Newpath collaborates with academics and founders to translate scientific discoveries into biotechnology companies across the US .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Metsera | Nov 2024 | Series B | - |
| Neumora | Oct 2022 | Series B | Co-investor |
| nChroma Bio | Dec 2024 | Series I | Lead |
| Amplitude Therapeutics | Mar 2024 | Seed | Co-investor |
| Autobahn Therapeutics | Jul 2024 | Series C | Lead |
For institutional investors. Book with your work email.
Key People
Daniel Yadegar
Co-Founder and Chief Medical Officer
Thomas Cahill
Co-Founder
Tom M. Thomas
Investor, Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Newpath Partners based?
Newpath Partners is headquartered in Boston, Massachusetts, United States.
When was Newpath Partners founded?
Newpath Partners was founded in 2018.
How many portfolio companies does Newpath Partners have?
Newpath Partners has 12 portfolio companies in Caplight's dataset.
What are some companies in Newpath Partners's portfolio?
Portfolio companies visible on Caplight include Metsera, Neumora, nChroma Bio, Amplitude Therapeutics, Autobahn Therapeutics.
What was Newpath Partners's most recent investment shown here?
Newpath Partners's most recent investment in this portfolio sample was in nChroma Bio in 2024.
What sectors does Newpath Partners focus on?
Newpath Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Newpath Partners focus on?
Newpath Partners typically invests at the Early stage.
What is Newpath Partners's AUM?
Newpath Partners's assets under management are estimated between $250.0M and $500.0M.